The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A02 | Drugs for acid related disorders | |
| 3 | A02A | Antacids | |
| 4 | A02AB | Aluminium compounds |
| Code | Title | |
|---|---|---|
| A02AB01 | Aluminium hydroxide | |
| A02AB02 | Aluminium hydroxide | |
| A02AB03 | Aluminium phosphate | |
| A02AB04 | Dihydroxialumini sodium carbonate | |
| A02AB05 | Aluminium acetoacetate | |
| A02AB06 | Aloglutamol | |
| A02AB07 | Aluminium glycinate | |
| A02AB10 | Combinations |
| Active Ingredient | Description | |
|---|---|---|
| Aluminium glycinate |
|
|
| Aluminium hydroxide |
Aluminium hydroxide is a slow-acting antacid. It is used to provide symptomatic relief in gastric hyperacidity. In addition, the antipeptic and demulcent activity of aluminium hydroxide helps to protect inflamed gastric mucosa against further irritation by gastric secretions. |
|
| Aluminium phosphate |
|
|
| Carbaldrate |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALU-CAP Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MAALOX Oral suspension | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
